MedPath

Comparison between laparoscopic (keyhole surgery) and robot-assisted surgery for patients with prostate cancer

Not Applicable
Completed
Conditions
Surgical treatment of localized prostate cancer
Surgery
Registration Number
ISRCTN11552140
Lead Sponsor
niversity of Turin
Brief Summary

2012 Results article in https://pubmed.ncbi.nlm.nih.gov/22840353/ (added 21/04/2022) 2024 Results article in https://doi.org/10.1002/pros.24702 Ten-year follow up (added 04/04/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
120
Inclusion Criteria

1. Aged between 50 and 75 years
2. Diagnosed with localised or locally advanced prostate adenocarcinoma (clinical stage T1-2 or T3, in each case N0, M0)
3. Gleason score between 2 and 10
4. PSA <20ng/ml

Exclusion Criteria

Patients who withdraw consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Postoperative urinary continence will be assessed with ICS questionnaire at 1, 3, 6, 12, 60 and 120 months after surgery.<br>2. Postoperative erectile function will be assessed with IIEF5 questionnaire at 1, 3, 6, 12, 60 and 120 months after surgery.
Secondary Outcome Measures
NameTimeMethod
1. Serum PSA levels will be assessed at 1, 3, 6, 12, 60 and 120 months after surgery<br>2. Intraoperative complications will be assessed using Clavien-Dindo scale during the intervention<br>3. Postoperative complications will be assessed using Clavien-Dindo scale at 1, 12, 60 and 120 months after surgery
© Copyright 2025. All Rights Reserved by MedPath